Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is a holisitic global pharmaceutical enterprise, committed to imparting inexpensive and progressive drugs for healthy lives globally. Through Reddy’s 3 corporations - Pharmaceutical Services and Active Ingredients, Global Generics, and Proprietary Products - this pharma giant of Dr. Reddy’s offers an ensemble of quality products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major healing focus is on gastro-intestinal, cardiovascular, diabetology, oncology, ache control, and anti-infective pharma products currently. Dr.Reddy’s major markets consist of India, USA, Russia-CIS, and Europe; other select geographies are developing as emerging markets. For more informaiton, log on to: www.Drreddys.com